BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19208748)

  • 1. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.
    Seeliger H; Camaj P; Ischenko I; Kleespies A; De Toni EN; Thieme SE; Blum H; Assmann G; Jauch KW; Bruns CJ
    Mol Cancer Res; 2009 Feb; 7(2):189-98. PubMed ID: 19208748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer.
    Hotz B; Backer MV; Backer JM; Buhr HJ; Hotz HG
    Neoplasia; 2010 Oct; 12(10):797-806. PubMed ID: 20927318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.
    Pang X; Zhang L; Lai L; Chen J; Wu Y; Yi Z; Zhang J; Qu W; Aggarwal BB; Liu M
    Carcinogenesis; 2011 Jun; 32(6):904-12. PubMed ID: 21427164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
    Lu YY; Jing DD; Xu M; Wu K; Wang XP
    World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis.
    Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J
    Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.
    Canu B; Fioravanti A; Orlandi P; Di Desidero T; Alì G; Fontanini G; Di Paolo A; Del Tacca M; Danesi R; Bocci G
    Neoplasia; 2011 Mar; 13(3):217-29. PubMed ID: 21390185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
    Taeger J; Moser C; Hellerbrand C; Mycielska ME; Glockzin G; Schlitt HJ; Geissler EK; Stoeltzing O; Lang SA
    Mol Cancer Ther; 2011 Nov; 10(11):2157-67. PubMed ID: 21885862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis.
    Rothmeier AS; Schneiders UM; Wiedmann RM; Ischenko I; Bruns CJ; Rudy A; Zahler S; Vollmar AM
    Int J Cancer; 2010 Sep; 127(5):1096-105. PubMed ID: 20143389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
    Berchtold S; Grünwald B; Krüger A; Reithmeier A; Hähl T; Cheng T; Feuchtinger A; Born D; Erkan M; Kleeff J; Esposito I
    Cancer Lett; 2015 Jan; 356(2 Pt B):721-32. PubMed ID: 25449434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.
    Qin J; Chen X; Yu-Lee LY; Tsai MJ; Tsai SY
    Cancer Res; 2010 Nov; 70(21):8812-21. PubMed ID: 20978203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
    Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo.
    Song EL; Hou YP; Yu SP; Chen SG; Huang JT; Luo T; Kong LP; Xu J; Wang HQ
    Gynecol Oncol; 2011 Apr; 121(1):174-80. PubMed ID: 21163514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
    Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
    Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
    Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
    Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell context-dependent dual effects of EFEMP1 stabilizes subpopulation equilibrium in responding to changes of in vivo growth environment.
    Hu Y; Ke C; Ru N; Chen Y; Yu L; Siegel ER; Linskey ME; Wang P; Zhou YH
    Oncotarget; 2015 Oct; 6(31):30762-72. PubMed ID: 26307682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference.
    Wang S; Liu H; Ren L; Pan Y; Zhang Y
    Neoplasia; 2008 Apr; 10(4):399-407. PubMed ID: 18392139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.